KRONOX
Kronox Lab Sciences Limited
Each stock's 10,000-path forecast, rendered as light.
Kronox Lab Sciences Limited (KRONOX) Stock Analysis & Case Study
Is KRONOX a good buy? The data-driven verdict.
Kronox Lab Sciences Limited (KRONOX) trades at ₹164,on the numbers it worth a closer look, a Downstox Snapshot Score of 68/100.
On the numbers, Kronox Lab Sciences Limited (KRONOX) worth a closer look, a Downstox Snapshot Score of 68/100, weighing fairly valued at 21.9× earnings, ROE of 26.8%, a 51% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
KRONOX fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How KRONOX ranks against the 2,373 companies in our screener
- KRONOX's market cap of 607 Cr ranks in the 30th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- KRONOX's book value of ₹31 ranks in the 24th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- KRONOX's promoter holding of 74.2% ranks in the 87th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- KRONOX's 3-year profit (PAT) growth of 19.0% ranks in the 55th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- KRONOX's 3-year revenue growth of 2.0% ranks in the 27th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- KRONOX's debt-to-equity ratio of 0.02x is lower than 94% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is KRONOX overvalued? KRONOX P/E vs peers
KRONOX trades at 21.9× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
KRONOX share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.1y of KRONOX history (1%/yr drift, 44%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| KRONOX 2027 | ₹95 | ₹165 | ₹287 | +1% |
| KRONOX 2028 | ₹75 | ₹167 | ₹367 | +2% |
| KRONOX 2029 | ₹62 | ₹168 | ₹452 | +3% |
| KRONOX 2030 | ₹53 | ₹170 | ₹541 | +4% |
| KRONOX 2031 | ₹47 | ₹171 | ₹617 | +5% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability KRONOX goes up, or doubles?
The bull case for KRONOX
- KRONOX's P/E of 21.9x is lower than 59% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- KRONOX's return on equity of 26.8% ranks in the 91st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- KRONOX's return on capital employed of 36.0% ranks in the top 4% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹452.
The bear case & risks
- No model or past record guarantees future returns, treat this as one input, not a decision.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹62.
KRONOX volatility & expected range, how bumpy is the ride?
Over the last 2.1 years KRONOX compounded at 1%/year with annualized volatility of 44%. That volatility implies a 1-year 80% range of ₹95-₹287, the honest backbone behind any single price target.
KRONOX price forecast, the full 60-month probability fan
KRONOX price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds KRONOX hits common targets within the simulated horizon?
Full multi-horizon detail on the KRONOX price target & forecast page.
KRONOX Piotroski F-Score: 6/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. KRONOX scores 6/8, mixed financial health.
KRONOX MTF margin & leverage across 4 brokers
Margin Trading Facility lets you buy KRONOX with part of the capital. Lower margin % = higher leverage. Rates compared across 4 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Zerodha | 50.00% | 2.0× |
| Groww | 34.50% | 2.9× |
| Pocketful | 50.00% | 2.0× |
| Share IndiaCHEAPEST | 34.37% | 2.9× |
Compare every broker on the KRONOX MTF page.
About Kronox Lab Sciences Limited: sector, index & market-cap context
Kronox Lab Sciences Limited (KRONOX) is a small-cap NSE-listed company, with a market capitalisation of ₹607 Cr. See more stocks on our screener.
How the KRONOX Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Kronox Lab Sciences Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
KRONOX analysis, FAQs
Is Kronox Lab Sciences Limited (KRONOX) a good buy?
On the numbers, Kronox Lab Sciences Limited (KRONOX) worth a closer look, a Downstox Snapshot Score of 68/100, weighing fairly valued at 21.9× earnings, ROE of 26.8%, a 51% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is KRONOX overvalued or undervalued?
KRONOX trades at 21.9× earnings, fairly valued versus the ~22× long-run Nifty average.
What is the KRONOX share price target for 2031?
KRONOX's probability-weighted 2031 median target is ₹171, with an 80% range of ₹47-₹617 (10,000-path Monte-Carlo).
What is the probability KRONOX doubles in 5 years?
The modelled probability of KRONOX reaching ₹327 (2×) within 5 years is 26%.
What is the bull case for KRONOX?
KRONOX's P/E of 21.9x is lower than 59% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. KRONOX's return on equity of 26.8% ranks in the 91st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. KRONOX's return on capital employed of 36.0% ranks in the top 4% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
What are the risks in KRONOX?
No model or past record guarantees future returns, treat this as one input, not a decision.